Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix A Statement of Task An ad hoc committee will plan and host a 1.5-day public workshop to facilitate discussion focused on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in terms of drug pricing and access. The meeting will feature invited presentations and panel discussions on topics that may include how federal funding for biomedical research, particularly via the National Institutes of Health (NIH), has contributed to new drug development, both directly and indirectly; the pricing of drugs that have benefited from federal investments in biomedical science; the role of technology and patent transfer to and from entrepreneurial organizations associated with NIH-funded research; potential ways to better track, quantify, and document NIH contributions to innovation in drug development; and potential strategies and policies to facilitate the translation of federally-funded biomedical research into innovations in drug development and to help ensure that the public has affordable access to those innovative medicines. The planning committee will develop the agenda, select and invite subject matter experts and discussants, and moderate the discussions. A proceedings of the event will be prepared in accordance with institutional guidelines. PREPUBLICATION COPY: UNCORRECTED PROOFS 57